Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alper Yetil"'
Autor:
Alper Yetil, Arvin M. Gouw, Benedict Anchang, Ramya Parameswaran, Stacey J. Adam, Dean W. Felsher, Sylvia K. Plevritis, Jan van Riggelen, Tahera Zabuawala
Publikováno v:
Oncotarget
MYC-induced T-ALL exhibit oncogene addiction. Addiction to MYC is a consequence of both cell-autonomous mechanisms, such as proliferative arrest, cellular senescence, and apoptosis, as well as non-cell autonomous mechanisms, such as shutdown of angio
Autor:
Martin Eilers, Tarik Möröy, Vincent Beuger, Christian Kosan, Peter S. Choi, Dean W. Felsher, Tobias Otto, Jan van Riggelen, Judith Müller, Alper Yetil
Publikováno v:
Genes & Development. 24:1281-1294
The Myc protein suppresses the transcription of several cyclin-dependent kinase inhibitors (CKIs) via binding to Miz1; whether this interaction is important for Myc's ability to induce or maintain tumorigenesis is not known. Here we show that the onc
Publikováno v:
Proceedings of the National Academy of Sciences. 104:13028-13033
Oncogene-induced senescence is an important mechanism by which normal cells are restrained from malignant transformation. Here we report that the suppression of the c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lym
Autor:
Xuesong Zhang, Shanshan Bai, Anh Hoang, Kanishka Sircar, Christopher G. Wood, Pheroze Tamboli, Alper Yetil, Arjan W. Griffioen, Nizar M. Tannir, Jianjun Gao, Zhiyong Ding, Mianen Sun, Padmanee Sharma, Eric Jonasch, Lijun Zhou, Axel Bex, Surena F. Matin, Xian De Liu, Jose A. Karam, Priya Rao, Amado J. Zurita, Sarathi Kalra, Peter German
Publikováno v:
Cancer Immunology Research, 3(9), 1017-1029. American Association for Cancer Research Inc.
Liu, X D, Hoang, A, Zhou, L J, Kalra, S, Yetil, A, Sun, M N, Ding, Z Y, Zhang, X S, Bai, S S, German, P, Tamboli, P, Rao, P, Karam, J A, Wood, C, Matin, S, Zurita, A, Bex, A, Griffioen, A W, Gao, J J, Sharma, P, Tannir, N, Sircar, K & Jonasch, E 2015, ' Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma ', Cancer Immunology Research, vol. 3, no. 9, pp. 1017-1029 . https://doi.org/10.1158/2326-6066.CIR-14-0244
Liu, X D, Hoang, A, Zhou, L J, Kalra, S, Yetil, A, Sun, M N, Ding, Z Y, Zhang, X S, Bai, S S, German, P, Tamboli, P, Rao, P, Karam, J A, Wood, C, Matin, S, Zurita, A, Bex, A, Griffioen, A W, Gao, J J, Sharma, P, Tannir, N, Sircar, K & Jonasch, E 2015, ' Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma ', Cancer Immunology Research, vol. 3, no. 9, pp. 1017-1029 . https://doi.org/10.1158/2326-6066.CIR-14-0244
Renal cell carcinoma (RCC) is an immunogenic and proangiogenic cancer, and antiangiogenic therapy is the current mainstay of treatment. Patients with RCC develop innate or adaptive resistance to antiangiogenic therapy. There is a need to identify bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f439ab15a080e8b9ff77de8add8cdf
https://research.vumc.nl/en/publications/5178595e-67cb-45e5-8e96-36e9fd331496
https://research.vumc.nl/en/publications/5178595e-67cb-45e5-8e96-36e9fd331496
Autor:
Lixin Dai, Jef D. Boeke, Anna Maria Niewiadomska, Wenfeng An, Alper Yetil, Kathryn A. O'Donnell, Jeffrey S. Han
Publikováno v:
Mobile DNA
Mobile DNA, Vol 2, Iss 1, p 2 (2011)
Mobile DNA, Vol 2, Iss 1, p 2 (2011)
Long interspersed elements, type 1(LINE-1, L1) are the most abundant and only active autonomous retrotransposons in the human genome. Native L1 elements are inefficiently expressed because of a transcription elongation defect thought to be caused by
Publikováno v:
Nature reviews. Cancer. 10(4)
Recently, MYC has been shown to serve as a direct regulator of ribosome biogenesis and therefore coordinates protein synthesis. Could the regulation of ribosome biogenesis by MYC be necessary for its role in tumorigenesis? MYC regulates the transcrip
Autor:
Kanishka Sircar, Mianen Sun, Padmanee Sharma, Jose A. Karam, Anh Hoang, Sarathi Kalra, Surena F. Matin, Christopher G. Wood, Amado J. Zurita, Pheroze Tamboli, Arjan W. Griffioen, Axel Bex, Priya Rao, Eric Jonasch, Jianjun Gao, Alper Yetil, Xian De Liu, Lijun Zhou, Zhiyong Ding, Nizar M. Tannir
Publikováno v:
Journal of Clinical Oncology. 33:419-419
419 Background: Renal cell carcinoma (RCC) is an immunogenic and proangiogenic cancer, and anti-angiogenic therapy is the current mainstay of treatment. RCC patients develop innate or adaptive resistance to anti-angiogenic therapy. There is a need to
Autor:
Alper Yetil, P. Rao, Anh G Hoang, Shanshan Bai, Surena F. Matin, Kanishka Sircar, Jose A. Karam, Xian De Liu, Zhiyong Ding, Christopher G. Wood, Pheroze Tamboli, Maxine Sun, Lijun Zhou, Nizar M. Tannir, Eric Jonasch, Amado J. Zurita, Sarathi Kalra, X. Zhang, Peter German
Publikováno v:
European Journal of Cancer. 50:172
Publikováno v:
Cancer Research. 74:29-29
Background: Anti-angiogenic agents targeting the VEGF pathway have improved the outcomes of patients with metastatic renal cell carcinoma (mRCC), but therapy resistance consistently occurs. In RCC, the presence of increased intratumoral and periphera
Autor:
Christopher G. Wood, Surena F. Matin, Eric Jonasch, Alper Yetil, Hai T. Tran, Xuemei Wang, John V. Heymach, Amado J. Zurita, Nizar M. Tannir
Publikováno v:
Cancer Research. 73:4645-4645
Purpose: The main objectives of this exploratory analysis were to identify biomarkers in blood associated with clinical benefit from bevacizumab, and to assess CAF changes related to nephrectomy (Nx) in mRCC. Methods: Plasma samples were obtained fro